Original citation: J Clin Invest. 2012;122(1):33–47. https://doi.org/10.1172/JCI58849
Citation for this corrigendum: J Clin Invest. 2021;131(22):e155916.. https://doi.org/10.1172/JCI155916
The authors recently became aware that the image presented in the original Supplemental Figure 5D as miR-30e* PGC#2 was identical to the image in Supplemental Figure 8E, NC U87MG-miR-30e/30e*, and that the image presented in the original Supplemental Figure 5E as miR-30e* inhibitor PGC#2 was identical to the image in Figure 8A, miR-30e* inhibitor U87MG. After review of the original data, the authors determined that the errors were made in Supplemental Figure 5E and Supplemental Figure 5D. An institutional review committee concluded that the errors in Supplemental Figure 5D and Supplemental Figure 5E were inadvertent and recommended correction. The authors provided the correct version of Supplemental Figure 5D and Supplemental Figure 5E with data obtained from repeated experiments. The correct version is shown below and in the updated supplemental data.
Supplemental Figure 5.
The authors regret the errors.
Version 1. 11/15/2021
Electronic publication